Actionnariat et activité des initiés pour Compugen Ltd. (CGEN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.41 |
| Capitalisation | $228M |
| Bourse | NASDAQ |
| Pays | IL |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-29 | Levine Zurit | A-Award | 18,000 | |
| 2026-07-29 | Levine Zurit | A-Award | 24,000 | $54K |
| 2026-07-29 | Silberman David | A-Award | 19,500 | |
| 2026-07-29 | Silberman David | A-Award | 26,000 | $59K |
| 2026-07-29 | Ophir Eran | A-Award | 200,000 | $452K |
| 2026-07-29 | Cohen-Dayag Anat | A-Award | 100,000 | $226K |
| 2026-07-29 | Perry Eran | A-Award | 7,500 | |
| 2026-07-29 | Perry Eran | A-Award | 10,000 | $23K |
| 2026-07-29 | Ferre Pierre | A-Award | 70,000 | $280K |
| 2026-07-29 | Kredo Russo Sharon | A-Award | 18,000 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $61.5M | $30.4M | $45.7M | $9.8M | $7.1M | $7.8M | $11.1M | $13.9M | $18.2M | $90.6M |
| Placements à Court Terme | 0 | 0 | 0 | $34.0M | $116.6M | $109.2M | $72.3M | $36.8M | $85.0M | $55.0M |
| Créances | $82000 | $51000 | $167000 | $341000 | $2.0M | $188000 | $317000 | $61.3M | $269000 | $294000 |
| Stocks | -$2.1M | -$1.7M | -$1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $62.7M | $31.2M | $46.6M | $45.0M | $129.1M | $123.2M | $86.1M | $114.6M | $106.0M | $148.0M |
| Immobilisations Corporelles | $6.0M | $4.6M | $3.4M | $5.6M | $4.5M | $3.9M | $3.4M | $2.5M | $3.7M | $3.2M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Totaux | $71.1M | $38.7M | $53.2M | $53.8M | $138.3M | $132.2M | $94.2M | $121.3M | $115.0M | $156.9M |
| Dettes Fournisseurs | $1.3M | $3.4M | $2.9M | $1.1M | $1.4M | $4.6M | $1.8M | $3.5M | $1.8M | $2.4M |
| Dette à Court Terme | 0 | 0 | 0 | $600000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $4.7M | $6.2M | $10.0M | $6.8M | $10.5M | $17.1M | $11.9M | $26.3M | $20.2M | $22.6M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $7.6M | $9.4M | $15.9M | $15.4M | $18.5M | $25.5M | $16.5M | $55.8M | $60.1M | $54.1M |
| Réserves | -$271.0M | -$308.2M | -$330.8M | -$358.2M | -$387.9M | -$422.1M | -$455.8M | -$474.5M | -$488.8M | -$453.4M |
| Capitaux Propres | $63.5M | $29.3M | $37.2M | $38.3M | $119.8M | $106.7M | $77.7M | $65.6M | $54.9M | $102.7M |
| Dette Totale | 0 | 0 | 0 | $3.6M | $3.2M | $2.8M | $1.9M | $1.4M | $2.9M | $3.0M |
| Dette Nette | -$61.5M | -$30.4M | -$45.7M | -$40.3M | -$120.6M | -$114.3M | -$81.4M | -$49.3M | -$100.3M | -$142.7M |
| Fonds de Roulement | $57.9M | $25.0M | $36.6M | $38.2M | $118.6M | $106.1M | $74.2M | $88.3M | $85.8M | $125.5M |
Santé financière
| Dette / Capitaux propres | 0.03 |
| Ratio de liquidité | 5.72 |
| Piotroski F-Score | 6 |
| Altman Z-Score | -0.38 |
Rentabilité
| Rentabilité des capitaux propres | 42.57% |
| Rentabilité du capital investi | 26.00% |
| Rentabilité des actifs | 25.43% |
| Marge brute | 86.89% |
| Marge opérationnelle | 40.94% |
| Marge nette | 47.55% |
Entreprises liées: CRBP · CRDF · CYBN · IPHA · MIST · MOLN · NVCT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CGEN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions